<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The pharmacokinetics of <z:chebi fb="0" ids="2637">amikacin</z:chebi> in 10 patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> and 1 patient with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> were investigated </plain></SENT>
<SENT sid="1" pm="."><plain>At an administered dose of 7 mg/kg of body weight, a volume of distribution of 0.4 liters/kg, an elimination half-life of 3.0 h, and a total body clearance of 2.1 ml/min per kg, <z:chebi fb="0" ids="2637">amikacin</z:chebi> achieved a peak level in blood of 21 micrograms/ml </plain></SENT>
<SENT sid="2" pm="."><plain>Results of the study revealed that there was a marked increase in volume of distribution of <z:chebi fb="0" ids="2637">amikacin</z:chebi> in these patients compared with <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
</text></document>